CRC
LKFT

Curi RMB Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Curi RMB Capital’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,331
Closed -$758K – 608
2020
Q3 		$758K Hold
5,331
– – 0.03% 350
2020
Q2 		$1.05M Sell
5,331
-1,209
-18% -$250K 0.05% 298
2020
Q1 		$1.28M Sell
6,540
-7,784
-54% -$1.67M 0.06% 252
2019
Q4 		$2.96M Sell
14,324
-780
-5% -$144K 0.08% 221
2019
Q3 		$2.31M Buy
+15,104
New +$2.48M 0.06% 277

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Curi RMB Capital's LKFT Position: Q4 2020 in Review

Curi RMB Capital sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2020, closing a stake of 5,331 shares — an estimated $758K sold.

Curi RMB Capital first reported a position in LKFT in Q3 2019 and held it in 5 quarters. The position peaked at $2.96M in Q4 2019. 116 funds tracked by Wall St. Rank hold LKFT as of Q4 2020.

  • Curi RMB Capital reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Curi RMB Capital sold 5,331 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2020, an estimated $758K.
  • Curi RMB Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and held it in 5 quarters.
  • Curi RMB Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.96M in Q4 2019.
  • 116 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2020.

Based on Curi RMB Capital's 13F filing for Q4 2020, filed 11 Feb 2021.